Quantcast

Latest B-cell chronic lymphocytic leukemia Stories

2014-12-16 08:32:27

Funds Will Support Research into Treating Patients Who Have Received Chemotherapy For Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia NEW YORK, Dec.

2014-12-12 08:26:10

SUNNYVALE, Calif., Dec.

2014-12-09 00:20:42

Follow-up data from the Phase 2 PCYC-1104 trial presented at the American Society of Hematology Annual Meeting show sustained efficacy and safety over time SAN FRANCISCO and RARITAN, N.J.,

2014-12-09 00:20:34

- Note: This press release corresponds to abstracts 4453 and 4471 SAN FRANCISCO, Dec.

2014-12-08 20:20:41

IMBRUVICA data presented at the American Society of Hematology Annual Meeting show 79 percent of CLL patients with del 17p were progression-free at 12 months SAN FRANCISCO and RARITAN, N.J.,

2014-12-08 20:20:32

Data Show 84% Progression-Free Survival Rate at One Year and Improvement in Quality of Life SAN FRANCISCO, Dec. 8, 2014 /PRNewswire/ -- Pharmacyclics, Inc.

2014-12-08 20:20:20

- Note: This press release corresponds to abstracts 627 and 1998. SAN FRANCISCO, Dec. 8, 2014 /PRNewswire/ -- New IMBRUVICA(®) (ibrutinib) Phase II data announced by Pharmacyclics, Inc.

2014-12-07 20:21:07

- AbbVie Presents for the First Time Results from the Venetoclax Phase 2 Program in Acute Myelogenous Leukemia NORTH CHICAGO, Ill., Dec.

2014-12-07 00:21:08

Results Show Durable Responses in High Risk Patient Population MARTINSRIED, Germany, MUNICH and MONROVIA, Calif., Dec.

2014-12-06 23:02:31

TG02 demonstrates ability to mobilize difficult-to-kill leukemic stem cells and render them vulnerable to chemotherapy. San Diego, California (PRWEB) December


Word of the Day
plim
  • To swell, as grain or wood with water.
The word 'plim' is probably a variant of the word 'plum'.
Related